Loading…
Globus Medical, Inc. is projected to rise to $87.99 by 2027, a +10% move from its current price of $80.26. GMED is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $78.53 | $80.26 | $82.03 | 0.00% |
| Aug 2 | $77.82 | $80.26 | $82.78 | 0.00% |
| Aug 3 | $77.28 | $80.26 | $83.35 | 0.00% |
| Aug 4 | $76.83 | $80.26 | $83.84 | 0.00% |
| Aug 5 | $76.44 | $80.26 | $84.28 | 0.00% |
| Aug 6 | $76.09 | $80.26 | $84.67 | 0.00% |
| Aug 7 | $75.76 | $80.26 | $85.03 | 0.00% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $75.76 | $80.26 | $85.03 | 0.00% |
| Week 2 | $73.97 | $80.27 | $87.10 | +0.01% |
| Week 3 | $72.63 | $80.27 | $88.71 | +0.01% |
| Week 4 | $71.52 | $80.27 | $90.10 | +0.02% |
| Week 5 | $70.56 | $80.28 | $91.34 | +0.02% |
| Week 6 | $69.69 | $80.28 | $92.48 | +0.03% |
| Week 7 | $68.91 | $80.28 | $93.53 | +0.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices.
It also provides interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. The company offers orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services.
The company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents.
Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Globus Medical, Inc. (GMED) is currently priced at $81.42 per share, with a market capitalization of $11.05B. It is ranked 869 by market cap.
The near-term forecast shows the 2026 average price at $81.42, with a range from $75.42 to $103.88 and neutral sentiment.
The multi-year forecast points to strong upside in later years: the average price is projected to $126.17 by 2030 (min $96.57, max $176.51) with ROI 55% and sentiment BULLISH; by 2040 the average price is $292.71 (min $199.39, max $465.89) with ROI 259.5% and sentiment BULLISH; and by 2050 the average price is $541.86 (min $338.28, max $932.88) with ROI 565.5% and sentiment BULLISH.
A major floor 13.0% below — a decisive break under it would weaken the trend.
The nearest floor, 6.0% below — buyers have tended to step in here.
The nearest ceiling, 7.5% above — a clean break opens room to run.
A major ceiling 20.6% above — clearing it would confirm fresh momentum.
Key GMED support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GMED market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $79.40 | Buy | $79.58 | Buy |
| MA 10 | $77.70 | Buy | $78.76 | Buy |
| MA 20 | $78.12 | Buy | $78.63 | Buy |
| MA 50 | $79.74 | Buy | $80.12 | Buy |
| MA 100 | $83.73 | Sell | $81.86 | Sell |
| MA 200 | $83.84 | Sell | $80.89 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.26 | Neutral |
| Stoch RSI (14) | 79.18 | Neutral |
| CCI (20) | 79.37 | Neutral |
| Williams %R (14) | -19.33 | Info |
| MACD (12,26,9) | 0.54 | Buy |
| ROC (12) | 5.86 | Buy |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 80.67 | Sell |
| TRIX (15) | -0.13 | Sell |
| Awesome (5,34) | 0.46 | Buy |
| Ultimate (7,14,28) | 66.67 | Neutral |
| Momentum (10) | -0.65 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 81.63 | Sell |
| ADX (14) | 10.21 | Neutral |
| ATR (14) | 1.65 | Info |
The 30-day technical picture is bullish, with RSI14 at 60.
SMA50 is $79.71 and SMA200 is $83.72, with support at $75.42 and resistance at $86.25.
The 30-day price range spans from $70.29 to $94.31, and annualized volatility is 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $75.42 | $80.26 | $102.22 | 0% | Neutral | |
| $71.45 | $87.99 | $113.73 | +10% | Neutral | |
| $74.13 | $93.32 | $124.41 | +16% | Neutral | |
| $82.72 | $106.05 | $144.83 | +32% | Bullish | |
| $94.31 | $122.85 | $171.23 | +53% | Bullish | |
| $108.52 | $143.41 | $203.49 | +79% | Bullish | |
| $115.29 | $154.40 | $222.62 | +92% | Bullish | |
| $117.76 | $159.68 | $233.61 | +99% | Bullish | |
| $128.49 | $176.30 | $261.41 | +120% | Bullish | |
| $128.60 | $178.45 | $267.91 | +122% | Bullish | |
| $193.68 | $282.65 | $447.25 | +252% | Bullish | |
| $328.05 | $521.08 | $890.81 | +549% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $75.42 | $80.26 | $93.55 | +0.00% |
| August 2026 | $68.93 | $80.56 | $96.09 | +0.37% |
| September 2026 | $68.26 | $80.31 | $96.83 | -0.32% |
| October 2026 | $69.78 | $82.53 | $100.36 | +2.77% |
| November 2026 | $70.89 | $84.21 | $103.11 | +2.03% |
| December 2026 | $69.56 | $82.96 | $102.22 | -1.48% |
Click any year to see its month-by-month GMED forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Globus Medical, Inc.'s 2026 outlook centres on $80.26, within a $75.42 to $102.22 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, GMED could reach as high as $113.73, with a base case around $87.99 and support toward $71.45 — roughly +10% from $80.26. A consolidation phase looks the most probable path here.
Expect GMED to range from $74.13 to $124.41 through 2028. The $93.32 average target implies a +16% move from current prices. That is up +6% on the projected 2027 average. Price action looks broadly range-bound.
The GMED price prediction for 2029 points to an average of $106.05 (low $82.72, high $144.83) — a potential gain of +32% on today's $80.26. Buyers look set to stay in control over this stretch.
In 2030, GMED is projected to trade between $94.31 and $171.23, averaging $122.85 — a potential gain of +53% from today's $80.26. That is up +16% on the projected 2029 average. Momentum favours further upside here.
Globus Medical, Inc.'s 2031 outlook centres on $143.41, within a $108.52 to $203.49 range. That is up +17% on the projected 2030 average. That marks a +79% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, GMED could reach as high as $222.62, with a base case around $154.40 and support toward $115.29 — roughly +92% from $80.26. Momentum favours further upside here.
Expect GMED to range from $117.76 to $233.61 through 2033. The $159.68 average target implies a +99% move from current prices. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The GMED price prediction for 2034 points to an average of $176.30 (low $128.49, high $261.41) — a potential gain of +120% on today's $80.26. Momentum favours further upside here.
In 2035, GMED is projected to trade between $128.60 and $267.91, averaging $178.45 — a potential gain of +122% from today's $80.26. That is up +1% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Globus Medical, Inc.'s 2040 outlook centres on $282.65, within a $193.68 to $447.25 range. That is up +58% on the projected 2035 average. That marks a +252% change versus current levels. Momentum favours further upside here.
By 2050, GMED could reach as high as $890.81, with a base case around $521.08 and support toward $328.05 — roughly +549% from $80.26. Buyers look set to stay in control over this stretch.
Investing $1,000 in GMED today (≈ 12.459507 GMED) could be worth
$6,492.37
+$5,492.37 (+549%) by 2050 · US Dollar
Based on the average projected GMED price of $521.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GMEDwould be worth at today's price.
$1,000 invested in GMED on Jul 30, 2025 (≈ 18.709074 GMED) would be worth
$1,501.59
+$501.59 (+50.2%) today · 1.50× · US Dollar
Based on a GMED entry price of $53.45 vs. today's $80.26.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $75.42 | $1,064.17 | +6.4% |
| 1 month ago | $79.01 | $1,015.82 | +1.6% |
| 3 months ago | $91.34 | $878.7 | -12.1% |
| 6 months ago | $90.68 | $885.09 | -11.5% |
| 1 year ago | $53.45 | $1,501.59 | +50.2% |
| All time (5.0y) ago | $82.67 | $970.85 | -2.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GMED forecast.
Our base-case forecast reaches $160.00 around 2034.
Implied market cap at $160.00: $18.13B
The multi-year forecast spans 2026 through 2050, showing a sustained uptrend. The 2026 average price is $81.42 and the 2030 average is $126.17, with intermediate steps including a 2035 average of $183.75 and a 2040 average of $292.71; by 2050 the average reaches $541.86.
ROI follows the rising path from 0% in 2026 to 55% by 2030, 259.5% by 2040, and 565.5% by 2050, all within a bullish sentiment framework for the later years.
These estimates carry uncertainty inherent to forecasts and are not guarantees; the volatility cited (40%) highlights potential price swings and the need for careful risk consideration.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $126.17, with a min of $96.57 and a max of $176.51. The ROI is 55% and sentiment is BULLISH.
Forecasts show neutral sentiment in 2026–2028 and bullish sentiment from 2029 onward, with the average price rising to $126.17 by 2030 and to $541.86 by 2050. ROI reaches up to 565.5%, but volatility is 40%, so these are estimates and not guarantees.
Yes. The 2040 forecast shows an average price of $292.71 with a min of $199.39 and a max of $465.89, indicating $200 is surpassed by 2040 and supported by a 259.5% ROI.
Current price is $81.42 and market cap is $11.05B.
The 2050 forecast shows an average price of $541.86, with a min of $338.28 and a max of $932.88. ROI is 565.5% and sentiment is BULLISH.
Globus Medical, Inc. Community Discussion
0Share your Globus Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.